Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Clinical trial NCT05910710 · UNKNOWN
Trial details
- NCT number
- NCT05910710
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-02
- Primary completion
- 2025-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.